MORGAN STANLEY - PROTEOSTASIS THERAPEUTICS IN ownership

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$4,000
-20.0%
4,0000.0%0.00%
Q2 2020$5,0000.0%4,0000.0%0.00%
Q1 2020$5,000
-44.4%
4,0000.0%0.00%
Q4 2019$9,0004,000
+399900.0%
0.00%
Q3 2019$01
-99.3%
0.00%
Q2 2019$0
-100.0%
139
-97.7%
0.00%
Q1 2019$7,000
-96.0%
6,162
-88.5%
0.00%
Q4 2018$174,000
+72.3%
53,601
+28.4%
0.00%
Q3 2018$101,000
-34.0%
41,750
-23.9%
0.00%
Q2 2018$153,000
+24.4%
54,895
+111.4%
0.00%
Q1 2018$123,000
-40.0%
25,966
-26.1%
0.00%
Q4 2017$205,000
-1.4%
35,154
-64.5%
0.00%
Q3 2017$208,000
+307.8%
99,066
+810.5%
0.00%
Q2 2017$51,000
-87.5%
10,880
-79.1%
0.00%
Q1 2017$408,000
-53.5%
52,074
-27.2%
0.00%
Q4 2016$878,000
+175.2%
71,490
+249.1%
0.00%
Q3 2016$319,000
+5216.7%
20,476
+4210.7%
0.00%
Q2 2016$6,0004750.00%
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q4 2020.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders